Dr Ann McCormack

Chang N; Grayson JW; Mangussi-Gomes J; Fung S; Alvarado R; Winder M; Jonker BP; McCormack A; Harvey RJ, 2021, 'Assessment of magnetic resonance imaging criteria for the diagnosis of cavernous sinus invasion by pituitary tumors', Journal of Clinical Neuroscience, vol. 90, pp. 262 - 267, http://dx.doi.org/10.1016/j.jocn.2021.06.010

Grayson JW; Nayak A; Winder M; Jonker B; Alvarado R; Barham H; Mccormack A; Harvey RJ, 2021, 'Multidisciplinary Team Care in the Surgical Management of Pituitary Adenoma', Journal of Neurological Surgery, Part B: Skull Base, vol. 82, pp. 295 - 302, http://dx.doi.org/10.1055/s-0039-1700498

Tritos NA; Fazeli PK; McCormack A; Mallea-Gil SM; Pineyro MM; Christ-Crain M; Frara S; Labadzhyan A; Ioachimescu AG; Shimon I; Takahashi Y; Gurnell M; Fleseriu M, 2021, 'Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas', PITUITARY, http://dx.doi.org/10.1007/s11102-021-01170-3

Lenders NF; Wilkinson AC; Wong SJ; Shein TT; Harvey RJ; Inder WJ; Earls PE; McCormack AI, 2021, 'Transcription factor immunohistochemistry in the diagnosis of pituitary tumours', European Journal of Endocrinology, vol. 184, pp. 891 - 901, http://dx.doi.org/10.1530/EJE-20-1273

Lenders NF; Wilkinson AC; Wong SJ; Shein TT; Harvey RJ; Inder WJ; Earls PE; McCormack AI, 2021, 'Transcription Factor Immunohistochemistry in the Diagnosis of Pituitary Tumors', Journal of the Endocrine Society, vol. 5, pp. A651 - A651, http://dx.doi.org/10.1210/jendso/bvab048.1327

Lenders NF; Inder WJ; McCormack AI, 2021, 'Towards precision medicine for clinically non-functioning pituitary tumours', Clinical Endocrinology, http://dx.doi.org/10.1111/cen.14472

McCormack A, 2021, 'Childhood-onset prolactinomas—Should earlier surgery be considered?', Clinical Endocrinology, http://dx.doi.org/10.1111/cen.14477

Lenders NF; McCormack AI; Ho KKY, 2020, 'Management of endocrine disease: Does gender matter in the management of acromegaly?', European Journal of Endocrinology, vol. 182, pp. R67 - R82, http://dx.doi.org/10.1530/EJE-19-1023

De Sousa SMC; Baranoff J; Rushworth RL; Butler J; Sorbello J; Vorster J; Thompson T; Mccormack AI; Inder WJ; Torpy DJ, 2020, 'Impulse Control Disorders in Dopamine Agonist-Treated Hyperprolactinemia: Prevalence and Risk Factors', Journal of Clinical Endocrinology and Metabolism, vol. 105, http://dx.doi.org/10.1210/clinem/dgz076

Fleseriu M; Buchfelder M; Cetas JS; Fazeli PK; Mallea-Gil SM; Gurnell M; McCormack A; Pineyro MM; Syro LV; Tritos NA; Marcus HJ, 2020, 'Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic—an international perspective', Pituitary, vol. 23, pp. 327 - 337, http://dx.doi.org/10.1007/s11102-020-01059-7

Stroud A; Dhaliwal P; Alvarado R; Winder MJ; Jonker BP; Grayson JW; Hamizan A; Harvey RJ; McCormack A, 2020, 'Outcomes of pituitary surgery for Cushing’s disease: a systematic review and meta-analysis', Pituitary, vol. 23, pp. 595 - 609, http://dx.doi.org/10.1007/s11102-020-01066-8

Cho J; Grayson JW; Christensen J; Winder MJ; Sheehy J; Steel T; Bentivoglio P; Barham HP; McCormack A; Harvey RJ, 2020, 'Long-Term Sinonasal Function Following Transnasal Pituitary Surgery: A Comparison of Surgical Approach', American Journal of Rhinology and Allergy, vol. 34, pp. 361 - 368, http://dx.doi.org/10.1177/1945892419896788

Lamb LS; Sim HW; McCormack AI, 2020, 'Exploring the role of novel medical therapies for aggressive pituitary tumors: A review of the literature—“are we there yet?”', Cancers, vol. 12, http://dx.doi.org/10.3390/cancers12020308

Trouillas J; Jaffrain-Rea ML; Vasiljevic A; Dekkers O; Popovic V; Wierinckx A; McCormack A; Petersenn S; Burman P; Raverot G; Villa C, 2020, 'Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician’s questions', Reviews in Endocrine and Metabolic Disorders, vol. 21, pp. 243 - 251, http://dx.doi.org/10.1007/s11154-020-09562-9

Lamb LS; Sim HW; McCormack AI, 2020, 'Case Report: A Case of Pituitary Carcinoma Treated With Sequential Dual Immunotherapy and Vascular Endothelial Growth Factor Inhibition Therapy', Frontiers in Endocrinology, vol. 11, http://dx.doi.org/10.3389/fendo.2020.576027

Burman P; Lamb L; McCormack A, 2020, 'Temozolomide therapy for aggressive pituitary tumours – current understanding and future perspectives', Reviews in Endocrine and Metabolic Disorders, vol. 21, pp. 263 - 276, http://dx.doi.org/10.1007/s11154-020-09551-y

Wang M; Jonker B; Killen L; Bogum Y; McCormack A; Bishay RH, 2020, 'Fatal high-grade skull osteosarcoma 30 years following radiotherapy for Cushing’s disease', Endocrinology, Diabetes and Metabolism Case Reports, vol. 2020, pp. 1 - 7, http://dx.doi.org/10.1530/EDM-20-0062

McCabe MJ; Pinese M; Chan CL; Sheriff N; Thompson TJ; Grady J; Wong M; Gauthier MEA; Puttick C; Gayevskiy V; Hajdu E; Wong SQ; Barrett W; Earls P; Lukeis R; Cheng YY; Lin RCY; Thomas DM; Watkins DN; Dinger ME; McCormack AI; Cowley MJ, 2019, 'Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases', Cold Spring Harbor Molecular Case Studies, vol. 5, http://dx.doi.org/10.1101/mcs.a003764

Stroud A; Zhang J; McCormack A, 2019, 'Diagnosing Cushing’s disease in the context of chronic kidney disease: A case report and literature review', European Journal of Endocrinology, vol. 181, pp. K29 - K35, http://dx.doi.org/10.1530/EJE-19-0326

McCabe M; Gauthier M-E; Chan C-L; Thompson T; De Sousa S; Puttick C; Grady J; Gayevskiy V; Tao J; Ying K; Cipponi A; Deng N; Swarbrick A; Thomas M; kConFab ; Lord R; Johns A; Kohonen-Corish M; O'Toole S; Clark J; Mueller S; Gupta R; McCormack A; Dinger M; Cowley M, 2019, 'Development and validation of a targeted gene sequencing panel for application to disparate cancers', Scientific Reports

Trouillas J; Burman P; McCormack A; Petersenn S; Popovic V; Dekkers O; Raverot G, 2018, 'Aggressive pituitary tumours and carcinomas: Two sides of the same coin?', European Journal of Endocrinology, vol. 178, pp. C7 - C9, http://dx.doi.org/10.1530/EJE-18-0250

Trainer PJ; Newell-Price JDC; Ayuk J; Aylwin SJB; Rees A; Drake W; Chanson P; Brue T; Webb SM; Fajardo C; Aller J; McCormack AI; Torpy DJ; Tachas G; Atley L; Ryder D; Bidlingmaier M, 2018, 'A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly', European Journal of Endocrinology, vol. 179, pp. 97 - 108, http://dx.doi.org/10.1530/EJE-18-0138

Raverot G; Burman P; McCormack A; Heaney A; Petersenn S; Popovic V; Trouillas J; Dekkers OM, 2018, 'European society of endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas', European Journal of Endocrinology, vol. 178, pp. G1 - G24, http://dx.doi.org/10.1530/EJE-17-0796

Lenders N; McCormack A, 2018, 'Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma)', Pituitary, vol. 21, pp. 217 - 229, http://dx.doi.org/10.1007/s11102-017-0857-z

McCormack A; Dekkers OM; Petersenn S; Popovic V; Trouillas J; Raverot G; Burman P; Harrison A; Hubalewska-Dydejezky A; Assie G; Bach L; Batisse-Lignier M; Berinder K; Bilbao I; Bonnet F; Bresson D; Bruno O; Campdera M; Caron P; Castinetti F; Ceccato F; Chabre O; Chanson P; Christ E; Cloix L; Cortet C; Criniere L; Cuatrecasas G; Debono M; Delemer B; Desailloud R; Deutschbein T; Dusek T; Engström BE; Faustini-Fustini M; Franck S; Garcia C; Greenman Y; Gil SM; Mantovani G; Gurnell M; Heaney A; Henley D; Higham C; Hoving EW; Höybye C; Ichihara A; Jaffrain-Rea ML; Johannsson G; Jorgensen JOL; Jublanc C; Komor J; Korbonits M; Kralievic I; Larrieu-Ciron D; Lasolle H; Laws E; Losa M; Maiter D; Marcocci C; Marques OC; Mazzuco TL; Micko A; Bourcigaux N; Neggers S; Newell-Price J; Perez-Berida B; Ortiz LD; Ragnarsson O; Ragonese M; Reincke M; Sadoul JL; Shimatsu A; Syro LV; Taillandier L; Toth M; Usui T; Valkusz Z; Vila G; Whitelaw B; Zatelli MC, 2018, 'Treatment of aggressive pituitary tumours and carcinomas: Results of a European Society of Endocrinology (ESE) survey 2016', European Journal of Endocrinology, vol. 178, pp. 265 - 276, http://dx.doi.org/10.1530/EJE-17-0933

Sheriff N; McCormack AI, 2017, 'How useful is urinary-free cortisol in the clinic?', Biomarkers in Medicine, vol. 11, pp. 1009 - 1016, http://dx.doi.org/10.2217/bmm-2016-0311

De Sousa SMC; McCormack AI; McGrath S; Torpy DJ, 2017, 'Prolactin correction for adequacy of petrosal sinus cannulation may diminish diagnostic accuracy in Cushing's disease', Clinical Endocrinology, vol. 87, pp. 515 - 522, http://dx.doi.org/10.1111/cen.13401

De Sousa SMC; McCabe MJ; Wu K; Roscioli T; Gayevskiy V; Brook K; Rawlings L; Scott HS; Thompson TJ; Earls P; Gill AJ; Cowley MJ; Dinger ME; McCormack AI, 2017, 'Germline variants in familial pituitary tumour syndrome genes are common in young patients and families with additional endocrine tumours', European Journal of Endocrinology, vol. 176, pp. 635 - 644, http://dx.doi.org/10.1530/EJE-16-0944

McCormack AI; Burt MG, 2017, 'Optimising pituitary surgery outcomes in Australia: how much does size matter?', Internal Medicine Journal, vol. 47, pp. 1225 - 1227, http://dx.doi.org/10.1111/imj.13610

McCormack A; Dekkers OM; Petersenn S; Popovic V; Trouillas J; Raverot G; Burman P, 2017, 'Use of temozolomide in a large cohort of patients with aggressive pituitary tumours and pituitary carcinomas: Results from a European Society of Endocrinology (ESE) survey', Endocrine Abstracts, http://dx.doi.org/10.1530/endoabs.49.oc12.2

McCormack A, 2017, 'The role of genetic testing in pituitary tumours - who to test?', CLINICAL ENDOCRINOLOGY, vol. 86, pp. 31 - 31, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000393453600087&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

De Sousa SMC; Maiti K; Smith R; McCormack AI, 2016, 'Corticotrophin-releasing hormone (CRH) expression in the dermoid component of ovarian teratomas', Journal of the European Academy of Dermatology and Venereology, vol. 30, pp. 867 - 869, http://dx.doi.org/10.1111/jdv.13035

De Sousa SMC; Earls P; McCormack AI, 2015, 'Pituitary hyperplasia: case series and literature review of an under-recognised and heterogeneous condition.', Endocrinol Diabetes Metab Case Rep, vol. 2015, pp. 150017, http://dx.doi.org/10.1530/EDM-15-0017

Trainer P; Newell-Price J; Ayuk J; Aylwin S; Rees A; Drake W; Chanson P; Brue T; Webb S; Fajardo C; Aller J; McCormack A; Torpy D; Atley L; Tachas G, 2015, 'Antisense oligomer therapy directed at the GH receptor is associated with reduction in circulating GHBP levels', Endocrine Abstracts, http://dx.doi.org/10.1530/endoabs.38.p308

Trainer P; Newell-Price J; Ayuk J; Aylwin S; Rees A; Drake W; Chanson P; Brue T; Webb S; Fajardo C; Aller J; McCormack A; Torpy D; Tachas G; Atley L; Bidlingmaier M, 2015, 'A phase 2 study of antisense oligonucleotide therapy directed at the GH receptor demonstrates lowering of serum IGF1 in patients with acromegaly.', Endocrine Abstracts, http://dx.doi.org/10.1530/endoabs.37.gp.19.10

Trainer PJ; Newell-Price J; Ayuk J; Aylwin S; Drake WM; Rees A; Chanson P; Brue T; Webb SM; Fajardo C; Aller J; McCormack A; Torpy DJ; Tachas G; Atley LM; Bidlingmaier M, 2014, 'OR7-8: A phase II randomised, open-label, parallelgroup study of the safety, tolerability, pharmacokinetics and efficacy of two subcutaneous dosing regimens of ATL1103 in adult patients with acromegaly', Growth Hormone & IGF Research, vol. 24, pp. S21 - S21, http://dx.doi.org/10.1016/s1096-6374(14)50054-8

Naziat A; Karavitaki N; Thakker R; Ansorge O; Sadler G; Gleeson F; Cranston T; McCormack A; Grossman AB; Shine B, 2013, 'Confusing genes: A patient with MEN2A and Cushing's disease', Clinical Endocrinology, vol. 78, pp. 966 - 968, http://dx.doi.org/10.1111/cen.12072

McCormack A; Kaplan W; Gill AJ; Little N; Cook R; Robinson B; Clifton-Bligh R, 2013, 'MGMT expression and pituitary tumours: Relationship to tumour biology', Pituitary, vol. 16, pp. 208 - 219, http://dx.doi.org/10.1007/s11102-012-0406-8

Rostomyan L; Daly A; Lila A; Lecoq A-L; Nachev E; Moraitis A; Naves L; Kranenburg D; Holdaway I; Filipponi S; Sievers C; Sahnoun-Fathallah M; Ojaniemi M; Sorkina E; Tichomirowa M; Ilovaiskaya I; Zacharin M; Bertherat J; Malchiodi E; Salvatori R; Barbosa SL-S; Maiter D; Mccormack A; Von Werder K; Rozhinskaya L; Dal J; Nazzari E; Auriemma R; Metzger D; Jorgensen JO; Dreval A; Ebeling T; Ferone D; Stalla G; Beck-Peccoz P; Aaltonen L; Colao A; Pronin V; Barlier A; Brue T; Rohmer V; Mukhopadhyay S; Borson-Chazot F; Neggers S; Jaffrain-Rea ML; Stratakis C; Chanson P; Zacharieva S; Petrossians P; Shah N; Beckers A, 2013, 'Le Gigantisme : les résultats d’une étude clinique et génétique internationale', Annales d'Endocrinologie, vol. 74, pp. 260 - 261, http://dx.doi.org/10.1016/j.ando.2013.07.083

Shein TT; Costin ML; McCormack A; Parker A; Earls P, 2013, 'Atypical pituitary adenomas – investigation and validation of the 2004 who criteria', Pathology, vol. 45, pp. S83 - S84, http://dx.doi.org/10.1097/01.pat.0000426942.30252.de

Greenfield JR; Mccormack AI, 2012, 'Medication to prevent breast cancer too much to swallow?', Medical Journal of Australia, vol. 196, pp. 314, http://dx.doi.org/10.5694/mja12.10056

McCormack A, 2012, 'Temozolomide in the treatment of aggressive pituitary tumours - An overview of existing knowledge and future perspectives', European Neurological Review, vol. 7, pp. 228 - 233, http://dx.doi.org/10.17925/enr.2012.07.04.228

McCormack A, 2012, 'Tmozolomide in the treatment of aggressive pituitary tumors - An overview of existing knowledge and future perspectives', US Endocrinology, vol. 8, pp. 112 - 117, http://dx.doi.org/10.17925/use.2012.08.02.112

McCormack A, 2012, 'Temozolomide in the treatment of aggressive pituitary tumours - an overview of existing knowledge and future perspectives', European Endocrinology, vol. 8, pp. 116 - 121, http://dx.doi.org/10.17925/ee.2012.08.02.116

Thompson J; Collett L; Langbart M; Purcell NJ; Boyd SJ; Yuminaga Y; Mccromack A, 2011, 'Using the ISBAR handover tool in junior medical officer handover: a study in a Australian tertiary hospital', Postgraduate Medical Journal, vol. 87, pp. 340 - 344, http://dx.doi.org/10.1136/pgmj.2010.105569

Mccromack A; Wass J; Grossman AB, 2011, 'Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status', European Journal of Clinical Investigation, vol. 41, pp. 1133 - 1148

Losa M; Mazza E; Terreni MR; McCormack A; Gill AJ; Motta M; Cangi MG; Talarico A; Mortini P; Reni M, 2010, 'Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: Experience in six cases', European Journal of Endocrinology, vol. 163, pp. 843 - 851, http://dx.doi.org/10.1530/EJE-10-0629

Glasziou P; Alexander J; Beller E; Clarke P; Chalmers J; MacMahon S; Cooper M; Ferrannini E; Grobbee D; Hamet P; Harrap S; Heller S; Lisheng L; Mancia G; Marre M; Mogensen C; Neal B; Yu Pan C; Patel A; Poulter N; Rodgers A; William B; Woodward M; Collins R; Holman R; Sleight P; Adams M; Branley M; Fulcher G; Jenkins B; Louis D; Lou W; Lowe H; McCormack A; Mitchell P; Ong S; Pollock C; Watson J; Wong T; Allen S; Bompoint S; Carreras A; Chen T; Flynn S; Gibbo S; Han D; Hough S; Jayne K; Joshi R; Kengne AP; Linn J; Monaghan H; Ng R; Perkovic V; Regaglia J; Schmidt M; Xin D; Yufang B; Holloway T; Gray B; Milne A; Adderkin A; Guertin MR; de Guise D; Liyuan M; Reid J; Subramaniam R; Wen W; Williamson K, 2007, 'Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial', Health and Quality of Life Outcomes, vol. 5, http://dx.doi.org/10.1186/1477-7525-5-21

Byrne MF; Chong HI; O'Donovan D; Sheehan KM; Leader MB; Kay E; McCormack A; Broe P; Murray FE, 2003, 'Idiopathic cholangiopathy in a biliary cast syndrome necessitating liver transplantation following head trauma', EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, vol. 15, pp. 415 - 417, http://dx.doi.org/10.1097/00042737-200304000-00013

McCormack AI, 2018, A perfect storm: towards reducing the risk of suicide in the medical profession., AMPCo, http://dx.doi.org/10.5694/mja18.00221, https://www.ncbi.nlm.nih.gov/pubmed/30376655

Shrosbree J; Pokorny A; Stone E; Epstein R; Mccormack A; Greenfield JR, 2016, Ectopic Cushing syndrome due to neuroendocrine prostatic cancer, http://dx.doi.org/10.1111/imj.13063

de Sousa SMC; Mccormack AI, 2016, Cutaneous lichen amyloidosis in multiple endocrine neoplasia, http://dx.doi.org/10.1111/imj.12925

Stroud A; Dhaliwal P; Alvarado R; Harvey RJ; Winder MJ; Jonker B; Grayson J; McCormack A, 2019, 'Predictors of remission and recurrence after pituitary surgery for Cushing’s disease', Melbourne, Australia, presented at 75th Annual Scientific Meeting of the Neurosurgical Society of Australasia, Melbourne, Australia, 21 August 2019 - 23 August 2019

McCabe MJ; Pinese M; Sheriff N; Fazekas M; McCormack AI; Dinger ME; Cowley MJ, 2018, 'Whole genome - and targeted capture - sequencing analysis of dual lung metastases and circulating tumour DNA (ctDNA) in a rare Primary Adrenocortical Carcinoma (ACC) case', in HUMAN GENOMICS, BIOMED CENTRAL LTD, Vol. 12, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427728400112&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sheriff N; McCormack A; Lam Q; Lim CF; Bretherton I; McWhinney B; Hepburn S; White C; Chiang C, 2017, 'Conundrum in Cushing's: UFC measured concurrently on three methods', in CLINICAL ENDOCRINOLOGY, WILEY, Perth, AUSTRALIA, Vol. 89, pp. 59 - 59, presented at Joint Annual Scientific Meetings of Endocrine-Society-of-Australia (ESA) and Society-for-Reproductive-Biology (SRB), Perth, AUSTRALIA, 27 August 2017 - 30 August 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436537900133&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sheriff N; De Sousa S; Manzoor N; Toogood V; Greenfield J; Jones G; McCormack A, 2017, 'Chicken or the egg: Cortisol dysregulation is frequent but overt Cushing's syndrome is rare in an unselected type 2 diabetes population', in CLINICAL ENDOCRINOLOGY, WILEY, Perth, AUSTRALIA, Vol. 89, pp. 60 - 60, presented at Joint Annual Scientific Meetings of Endocrine-Society-of-Australia (ESA) and Society-for-Reproductive-Biology (SRB), Perth, AUSTRALIA, 27 August 2017 - 30 August 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436537900136&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sheriff N; Pinese M; Fazekas M; McCabe M; Cowley M; McCormack AI, 2017, 'TrACCing the tumour', in CLINICAL ENDOCRINOLOGY, WILEY-BLACKWELL, Vol. 86, pp. 60 - 60, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000393453600153&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McCormack A, 2016, 'Urine free cortisol measurement: Clinical perspective.', in Pathology, England, Vol. 48 Suppl 1, pp. S17 - S18, England, http://dx.doi.org/10.1016/j.pathol.2015.12.049

McCabe M; Cowley M; De Sousa S; Pinese M; Gayevskiy V; Minoche A; McCormack A; Dinger M, 2016, 'Establishment of the Southern Hemisphere's First Clinically Accredited Whole Genome Sequencing Facility, and the Development of a Gene Sequencing Panel for Application to Disparate Cancer Types Including Pituitary', in HORMONE RESEARCH IN PAEDIATRICS, KARGER, Vol. 86, pp. 35 - 35, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000388504100071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

De Sousa SMC; Schofield L; Jones GRD; Greenfield JR; McCormack AI, 2015, 'Comparison of the insulin tolerance test against the glucagon stimulation and short Synacthen tests in patients with suspected hypopituitarism', in CLINICAL ENDOCRINOLOGY, WILEY, Adelaide, AUSTRALIA, Vol. 84, pp. 34 - 34, presented at Annual Scientific Meeting of the Endocrine-Society-of-Australia, Adelaide, AUSTRALIA, 23 August 2015 - 26 August 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000372310400094&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McCabe M; De Sousa S; Cowley M; Dinger M; McCormack A, 2015, 'Next generation sequencing: towards a new clinical frontier in the diagnosis and treatment of pituitary tumours', Vol. 35, presented at European Society of Paediactric Endocrinology, Barcelona, 01 February 2015 - 01 February 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209805102035&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

McCabe M; Lam A; Thompson T; Dinger M; McCormack A, 2015, 'Loss-of-function germline FGFR1 mutation identified in a patient with prolactinoma', presented at Endocrine Society of Australia, Annual Scientific Meeting, Adelaide, 01 January 2015 - 01 January 2015